2021-10-15
CTBE raised fund from SUCCESS program of Japan Science and Technology Agency (JST) . The company will accelerate development of the artificial ligament for ACL reconstruction and business development for the US market.
CTBE raised fund from SUCCESS program of Japan Science and Technology Agency (JST) . The company will accelerate development of the artificial ligament for ACL reconstruction and business development for the US market.
2022-06-29
Yoji Jokura has been appointed as Board Chairman and Chiaki Waki has been appointed as President&CEO.
2022-03-16
CTBE was accepted by Johnson & Johnson Innovation (Boston, U.S.A.) as the first startup company in Japan. It was also interviewed and posted by Nikkei Shimbun.
2021-11-11
CTBE was introduced by "Venture Tanbou" on "Nikkei Biotechnology & Business".
2021-10-20
CTBE was elected to "J-Startup", the program for supporting the global startup companies sponsored by Japanese governmental organizations (METI, JETRO and NEDO).
2021-10-15
CTBE raised fund from SUCCESS program of Japan Science and Technology Agency (JST) . The company will accelerate development of the artificial ligament for ACL reconstruction and business development for the US market.